Background: In Canada, many patients face substantial out-of-pocket costs for prescription medication, which may affect their ability to take their medications as prescribed. We sought to conduct a ...
See related research at On Oct. 10, 2024, Bill C-64 — comprising the first concrete measures to implement universal, single-payer, public pharmacare in Canada — became law.[1][2] As an initial step ...
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...
Self-reflection on attitudes and beliefs may mitigate bias and discrimination. Structural changes — for which funding is sometimes available — can ensure universal accessibility. Equitable access to h ...
KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...
Background: Standard pharmacotherapy for patients with heart failure with reduced ejection fraction (HFrEF) comprises “quadruple therapy” with a renin–angiotensin system inhibitor, a β-blocker, a ...
The parasympathetic pathway within the third cranial nerve induces pupil constriction, whereas the sympathetic pathway causes pupil dilation.1 Comparing pupil sizes in dim and bright lighting can help ...
Des épreuves diagnostiques sont recommandées si l’indice au Questionnaire canadien sur le risque de diabète (CANRISK) est de 19 ou plus Le diabète de type 2 à début précoce est associé à un risque 2 ...